Novartis | NVS - Passività Correnti

Prezzo Delle Azioni
145.47
Cambio Giornaliero
-2.06 -1.40%
Mensile
-3.46%
Annuale
29.62%
Q2 Previsione
142.62




Passività Correnti Cambiamento Data
AbbVie USD 43.29B 3.9B 2025-12
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Bausch Health Companies USD 4.18B 613M 2025-12
Biogen USD 3.35B 59.4M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Canopy Growth CAD 98.29M 17.19M 2025-12
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Drreddys Laboratories INR 1.76B 62.5M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Glaxosmithkline GBP 28.82B 144.79M 2025-12
J&J USD 57.72B 3.59B 2026-03
Merck USD 28.63B 2.59B 2025-09
Novartis USD 27.28B 4.72B 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Phibro Animal Health USD 282.37M 12.23M 2025-12
Prestige Brands USD 139.56M 4.95M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
Sanofi EUR 28.35B 9.32B 2025-12
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Zoetis USD 2.24B 428M 2025-12